MedTrace Logo

Hydrogen-oxygen Mixed Gas in the Treatment of Insomnia

NCT05248360 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-12-15

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of hydrogen-oxygen mixed gas inhalation in the treatment of insomnia.

Conditions

Interventions

DEVICE

Hydrogen-oxygen mixed gas(H2-O2) inhalation

H2-O2 inhalation, 900ml/min, 2h/d \* 4 weeks (≥5 days/week)

DEVICE

Air inhalation

Air inhalation, 900ml/min, 2h/d \* 4 weeks (≥5 days/week)

Sponsors & Collaborators

  • Second Affiliated Hospital of Soochow University

    lead OTHER

Principal Investigators

  • Chun-Feng Liu, MD · Second Affiliated Hospital of Soochow University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-11
Primary Completion
2023-09-01
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05248360 on ClinicalTrials.gov